Dr Richard Torbett is Chief Economist at EFPIA (European Federation of Pharmaceutical Industries and Associations). He is responsible for economic analysis as well as EFPIA’s relations with international economic institutions, notably the so-called Troika and the OECD. Richard’s current work focuses on the relationship between Health and Economic Growth.
Richard joined EFPIA in August 2012 having spent the previous six years at Pfizer Inc., most recently as Senior Director and Head of International Affairs. During his time at Pfizer Richard led the policy development work in developed countries outside the US. He also represented the company and wider pharmaceutical industry with a range of governments and international institutions.
Prior to joining the pharmaceutical industry, Richard worked as a government economist. He was a Senior Economist at the Department of Trade and Industry (DTI) in the UK. As a Government official, he held a number of posts at DTI, Cabinet Office and the European Commission. Richard has degrees in economics from the University of Sussex and the University of Grenoble. He Completed his PhD at the Science Policy Research Unit (SPRU), University of Sussex in 2001.
